• American Medical Systems (AMS; Minneapolis) said that the FDA has approved it AMS 700 with Inhibizone as the only inflatable penile prosthesis with clinical evidence showing a significant reduction in the rate of revision surgery due to infection. The company claims its AMS 700 with Inhibizone is the gold standard for penile implant technology and the only antibiotic-impregnated penile prosthesis on the market. The external silicone surfaces of the device's dual cylinders are impregnated with a proprietary combination of Minocycline Hydrochloride and Rifampin, which elute from the surface when implanted. For diabetic patients, who by the nature of their condition are at an increased risk of infection, the post-market study also concluded that the use of INHIBIZONE treated penile prosthesis resulted in a significant reduction in the rate of revisions due to infection in those receiving a first-time AMS 700 implant.

• Cayenne Medical (Scottsdale, Arizona) reported the launch of its CrossFix system for the repair of meniscal tears. The CrossFix system is a suture only device that creates a 3mm mattress stitch for a fast, strong, and reliable all-inside meniscal repair. The dual needle design instantly deploys a horizontal or vertical mattress with a pre-tied sliding knot through a single insertion into the meniscus. The device includes an incorporated cannula and depth limiter that controls needle penetration, reducing the risk of neurovascular injury. Cayenne says the CrossFix system offers surgeons the benefits of both open suturing and arthroscopic meniscal repair. The technology replicates results from "gold standard" open suturing techniques but through a faster and less invasive all-inside method.

• Power Medical Interventions (Langhorne, Pennsylvania) said that the i60 Mid Cut device was used in a procedure known as laparoscopic vertical gastroplasty. This procedure is designed to combat obesity through a novel, less invasive surgical procedure which takes approximately 30 minutes to perform. The procedure was successful at reducing the size of the patient's stomach, without removing the stomach. This minimally invasive procedure resulted in the patient losing 17 pounds in the first week following surgery. Enabled by PMI's computer-assisted, power-actuated surgical instruments and unique Mid Cut Reload, the laparoscopic vertical gastroplasties are minimally invasive surgical procedures designed to create a narrow sleeve in the stomach using staples without removing the stomach. As a result of the operation, a significant portion of the stomach is partially sealed off but left in place, reducing the overall size of the functioning stomach and restricting its intake potential.

• TwistDx (Cambridge, UK) reported the launch of its TwistAmp product range, DNA amplification products based on Recombinase Polymerase Amplification (RPA). Concurrently, TwistDx also launched the Twista portable, real-time fluorometer, an RPA reader. RPA is a technique the uses recombinase enzymes, used to amplify nucleic acids in any biological sample, with high analytical sensitivity and specificity. The Twista portable real-time fluorometer is a customized platform containing proprietary fluorescent probe systems developed by the company to accurately monitor RPA reactions. TwistAmp kits can be used in combination with various, widely used assay platforms, such as conventional analysis tools (e.g. on agarose gels), dipsticks, as well as broadly available fluorescence plate readers and real-time PCR machines.